Archean Chemical Industries Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags

Archean Chemical Industries (NSE:ACI) Full Year 2025 Results

Key Financial Results

• Revenue: ₹10.8b (down 19% from FY 2024).
• Net income: ₹1.62b (down 49% from FY 2024).
• Profit margin: 15% (down from 24% in FY 2024). The decrease in margin was driven by lower revenue.
• EPS: ₹13.13 (down from ₹25.90 in FY 2024).

Our free stock report includes 2 warning signs investors should be aware of before investing in Archean Chemical Industries. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Archean Chemical Industries Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 2.2%. Earnings per share (EPS) missed analyst estimates by 26%.

Looking ahead, revenue is forecast to grow 31% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in India.

Performance of the Indian Chemicals industry.

The company's shares are down 6.9% from a week ago.

Risk Analysis

We should say that we've discovered 2 warning signs for Archean Chemical Industries that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.